Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Cameron Harrison and Tom Layton
Conrad Harrison (l) and Thomas Layton (r) both received the prestigious Hunterian Professorships

Named after the pioneering surgeon and scientist John Hunter and dating back over two centuries, the Hunterian Professorship is among the most highly-regarded annual awards in the field of surgery.

Conrad Harrison, NIHR Doctoral Research Fellow at NDORMS has been awarded the Hunterian Professorship for his work on on outcome measurement in plastic surgery.

Conrad joined the University of Oxford in 2015 where he completed Academic Foundation and Core Surgical Training programmes. He holds an honorary contract with Oxford University Hospitals as a Specialty Registrar in Plastic and Reconstructive Surgery and has taken time out of clinical training to complete a DPhil. His research uses contemporary data science to improve the way we measure health outcomes.

Hunterian Professors are invited to give an annual Hunterian Lecture on their field of specialism and chosen research. Conrad will deliver his Hunterian lecture entitled ‘Transforming outcome measures in plastic surgery’ at the British Association of Plastic Reconstructive and Aesthetic Surgeons (BAPRAS) winter meeting on 1 December. 

Thomas Layton, Postdoctoral Clinical Research Fellow at the Kennedy Institute, was also awarded a 2022 Hunterian Professorship for his work on Dupuytren's disease.

Thomas studied Medicine at the University of Manchester before his foundation training in Oxford where he completed an Oxford-Celgene research fellowship working towards a DPhil in Cell and Molecular Biology.  He is now doing his core surgical training in Oxford and continuing his collaboration with BMS-Celgene as supervisor of a postdoctoral research fellowship aiming to explore and uncover central regulators of human liver fibrosis.

Tom’s Hunterian lecture ‘The single cell landscape of Dupuytren’s disease’ builds on his DPhil, which utilised advanced single cell technologies including CyTOF and scRNA-seq to define key molecular and cellular pathways governing fibrosis in Dupuytren's disease. His lecture will also be delivered at the BAPRAS meeting on 2 December.

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Dr Alex Clarke wins Emerging Leaders Prize for lupus research

Alex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation’s sixth Emerging Leaders Prize.

A new research computing platform advances the understanding of key biological processes in disease

To respond to advances in technology and try to answer an increasing range of biological questions, the Kennedy Institute has invested in a high-performance computing facility. We speak to Brian Marsden, Associate Professor of Research Informatics at the Kennedy to find out more.

Kennedy programmes support early career researchers

Since 2013 the Kennedy Institute of Rheumatology has been running a Career Development Programme, a scheme to help early career researchers launch their own independent laboratories, and more recently the Innovator Investigator Programme to bring new technologies to core research themes.

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.